Melio
3 known investors
Melio develops rapid diagnostic technology for bloodborne infections in neonatal care using microfluidics and machine learning, delivering results significantly faster than traditional blood cultures.
Investors · 3
Frequently asked questions
- What does Melio do?
- Melio develops rapid diagnostic technology for bloodborne infections in neonatal care using microfluidics and machine learning, delivering results significantly faster than traditional blood cultures.
- Who are Melio's investors?
- Melio's investors include Cove Fund, Lexi Ventures, LongeVC.